Written by Holly Alyssa MacCormick Ask Vito Imbasciani about his career and you will not hear a simple answer—you will hear a story of service to his country and to the people of California. Imbasciani, PhD, MD, FACS, Colonel (ret.), has chaired the board of the California Institute for Regenerative Medicine (CIRM) since March 28, … Continue reading A life of service: A conversation with CIRM Board Chair Vito Imbasciani
CIRM Board
A conversation with CIRM board member Yael Wyte
Written by Holly Alyssa MacCormick Yael Wyte knows all too well how difficult it can be to have or care for someone with Alzheimer’s Disease—she has been working with and advocating for people with Alzheimer's Disease for more than 20 years. Earlier this year, Wyte joined the board of the California Institute for Regenerative Medicine … Continue reading A conversation with CIRM board member Yael Wyte
Remembering CIRM board member and ALS patient advocate Fred Fisher
CIRM honors the contributions of Fred Fisher, MSW, LCSW, a dedicated member of our Independent Citizens’ Oversight Committee (ICOC) and a passionate patient advocate. Fred passed away in September. He joined the ICOC as the ALS patient advocate in June 2021 and served in many roles, including co‑chair of the Standards Working Group and member … Continue reading Remembering CIRM board member and ALS patient advocate Fred Fisher
CIRM Welcomes New Board Members
The California Institute for Regenerative Medicine (CIRM) welcomes a distinguished group of new board members and alternates, each bringing a wealth of experience and leadership in healthcare, research, and innovation. Joyce A. Sackey, MD, FACP Dr. Sackey joins CIRM as an alternate for Linda Boxer. As the inaugural Chief Equity, Diversity, and Inclusion Officer at … Continue reading CIRM Welcomes New Board Members
Kevin Xu joins governing board of California’s Stem Cell & Gene Therapy Agency
The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, is pleased to announce the appointment of Kevin Xu to its Independent Citizens’ Oversight Committee (ICOC), the official governing Board of the agency. Xu is CEO of MEBO International, an intellectual property management company responsible for managing “Human Body Regenerative … Continue reading Kevin Xu joins governing board of California’s Stem Cell & Gene Therapy Agency
Biden Appoints CIRM board member Ysabel Duron to National Cancer Advisory Board
President Biden appointed Ysabel Duron, the award-winning journalist, patient advocate, cancer survivor and board member of the California Institute for Regenerative Medicine (CIRM), to the National Cancer Advisory Board. Vital role The board plays a key role in guiding the national cancer research program and will complement the Cancer Moonshot initiative, which President Biden reignited … Continue reading Biden Appoints CIRM board member Ysabel Duron to National Cancer Advisory Board
Dr. Vito Imbasciani elected Chair of CIRM
Dr. Vito Imbasciani elected Chair of the California Institute for Regenerative Medicine (CIRM). Voters created CIRM in 2004 and renewed its funding in 2020 to advance stem cell and regenerative medicine research. Board Support At January’s meeting, the agency’s 35‑member Governing Board elected Imbasciani to a six‑year term. He succeeds Jonathan Thomas, who has served … Continue reading Dr. Vito Imbasciani elected Chair of CIRM
Why the future of regenerative medicine depends on students getting a living wage
The headline in the journal Nature was intended to grab attention and it definitely did that. It read: ‘The scandal of researchers paid less than a living wage’ The rest of the article built on that saying “The cost-of-living crisis is a fundamental threat for PhD scholars and early-career researchers. They need to be paid … Continue reading Why the future of regenerative medicine depends on students getting a living wage
Dr. Deborah Deas and Ysabel Duron recognized for their contributions to advancing public health
Dr. Deborah Deas The California Institute for Regenerative Medicine (CIRM) has two reasons to celebrate today. Earlier this month, Dr. Deborah Deas was elected as a member of the National Academy of Medicine, or NAM. Membership in the academy is one of the highest national honors in health and medicine. Dr. Deas is the vice … Continue reading Dr. Deborah Deas and Ysabel Duron recognized for their contributions to advancing public health
CIRM Board Approves Funding for New Clinical Trial Targeting Brain Tumors
The governing Board of the California Institute for Regenerative Medicine (CIRM) has awarded almost $12 million to carry out a clinical trial targeting brain tumors. This brings the total number of CIRM funded clinical trials to 83. $11,999,984 was awarded to Dr. Jana Portnow at the Beckman Research Institute of City of Hope. They are using Neural stem … Continue reading CIRM Board Approves Funding for New Clinical Trial Targeting Brain Tumors